Reports for METHYLPHENIDATE HYDROCHLORIDE

Ingredient

METHYLPHENIDATE HYDROCHLORIDE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2021-11-09 2022-01-06 148999
FOQUEST 85MG CAPSULE (CONTROLLED RELEASE) Resolved 2021-12-22 2022-01-27 151794
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2021-11-29 2022-01-29 150181
FOQUEST 55MG CAPSULE (CONTROLLED RELEASE) Resolved 2022-01-11 2022-02-17 152470
FOQUEST 70MG CAPSULE (CONTROLLED RELEASE) Resolved 2022-02-03 2022-02-17 154155
FOQUEST 45MG CAPSULE (CONTROLLED RELEASE) Resolved 2022-01-11 2022-02-26 152465
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2022-01-28 2022-03-24 153783
FOQUEST 55MG CAPSULE (CONTROLLED RELEASE) Resolved 2022-03-25 2022-04-04 157368
FOQUEST 70MG CAPSULE (CONTROLLED RELEASE) Resolved 2022-03-10 2022-04-05 156474
BIPHENTIN 20MG CAPSULE (EXTENDED RELEASE) Resolved 2022-03-10 2022-04-07 156480

Showing 71 to 80 of 198

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ METHYLPHENIDATE SR 20MG TABLET (EXTENDED-RELEASE) Discontinued 2022-05-24 2022-05-24 161221

Showing 11 to 11 of 11